Methylatropine

From WikiMD's WELLNESSPEDIA

Methylatropine (also known as Methscopolamine) is a pharmacological agent that belongs to the class of anticholinergic drugs. It is a quaternary ammonium compound and a derivative of scopolamine.

Chemistry[edit]

Methylatropine is a quaternary ammonium compound, which means it carries a positive charge. This makes it less able to cross the blood-brain barrier, resulting in fewer central nervous system effects compared to other anticholinergic drugs. It is a derivative of scopolamine, with a methyl group added to the nitrogen atom of the tropane ring.

Pharmacology[edit]

Methylatropine works by blocking the action of acetylcholine, a neurotransmitter that transmits signals in the nervous system. By blocking the receptors for acetylcholine, methylatropine reduces the activity of the parasympathetic nervous system, which controls various body functions such as heart rate, digestion, and salivation.

Medical uses[edit]

Methylatropine is used in medicine to reduce secretions in the mouth, throat, and stomach before surgery. It is also used to block the cardiac vagal reflexes during anesthesia and to treat peptic ulcers.

Side effects[edit]

Like other anticholinergic drugs, methylatropine can cause a range of side effects, including dry mouth, blurred vision, urinary retention, and constipation. In rare cases, it can cause severe allergic reactions.

See also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.